Toxic and therapeutic effects of methotrexate-folinic acid (leucovorin) in advanced cancer and leukemiaWriting committee for the southeastern cancer study group
Open Access
- 1 January 1971
- Vol. 28 (4) , 894-901
- https://doi.org/10.1002/1097-0142(1971)28:4<894::aid-cncr2820280412>3.0.co;2-i
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlatesJournal of Clinical Investigation, 1969
- Uptake as a Determinant of Methotrexate Response in Mouse LeukemiasScience, 1965
- Kinetics of proliferation of cancer cells in neoplastic effusions in manCancer, 1965
- Toxicity and Antitumor Effect Of Divided Doses of MethotrexateArchives of internal medicine (1960), 1965
- THE “INDUCTION” OF DIHYDROFOLIC REDUCTASE ACTIVITY IN LEUKOCYTES AND ERYTHROCYTES OF PATIENTS TREATED WITH AMETHOPTERIN*Journal of Clinical Investigation, 1963
- Defective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cellsBiochemical Pharmacology, 1962
- Increased Level of Dihydrofolic Reductase in Leucocytes of Patients Treated with AmethopterinNature, 1962
- Increased levels of folic acid reductase as a mechanism of resistance to amethopterin in leukemic cellsBiochemical Pharmacology, 1961
- Studies on the folic acid vitamins.II. The Acute toxicity of amethopterin in manCancer, 1960
- Inhibition of Dihydrofolic Reductase by Aminopterin and Amethopterin.Experimental Biology and Medicine, 1958